All In MedTech

Device Trial Radar · NCT07825792

Light Bulb Stimuli to Reduce Chronic Pain

Chromatic Retinal Stimulation to Reduce Chronic Pain and Pain Sensitivity Using Light Bulbs: A Pilot Randomized Crossover Trial

Last checked: Nov 20, 2026Latest source record: Nov 2, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

40

Planned (sponsor's estimate)

Start

Nov 9, 2026

Primary completion

Jan 1, 2028

Study completion Jan 1, 2028

Sponsor

Lead sponsor
University of North Carolina, Chapel HillAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Sep 17, 2026

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Crossover
Masking
Triple (participant, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This pilot randomized, double-blind, crossover clinical trial will evaluate the feasibility and preliminary efficacy of chromatic (colored) light exposure for reducing pain severity and pain sensitivity in adults with fibromyalgia or chronic widespread pain and fatigue. Participants will complete daily symptom surveys throughout the study and undergo patient-reported outcome assessments and quantitative sensory testing at multiple timepoints. Participants will be randomized to receive either S-cone stimulating chromatic light or equal-energy white light for 2 hours daily over a 7-day treatment period. Following a 1-week washout, participants will cross over to the alternate condition. Outcomes will examine feasibility, changes in pain severity, pain interference, and measures of pain sensitivity. Total study duration is approximately 35 days.

Conditions

  • Fibromyalgia
  • Musculoskeletal Pain

Interventions

  • S-Cone Stimulating Chromatic LightDevice

    Participants receive exposure to S-cone stimulating chromatic light delivered via programmed TUO light bulbs. Light is administered for 2 hours daily for 7 consecutive days, ideally between 5:00 a.m. and 10:00 a.m.. Participants use the light in their home environment while engaging in normal daily activities. Light intensity is maintained at a minimum of twice the ambient room illumination using an illuminometer provided by the study. This intervention is designed to selectively stimulate short-wavelength-sensitive (S-cone) photoreceptors.

  • Equal-Energy White LightDevice

    Participants receive exposure to a light that appears equal-energy white that flickers along the L/M axis delivered via programmed TUO light bulbs. Light is administered for 2 hours daily for 7 consecutive days, ideally between 5:00 a.m. and 10:00 a.m. Participants use the light in their home environment while engaging in normal daily activities. Light intensity is maintained at a minimum of twice the ambient room illumination using an illuminometer provided by the study. This intervention serves as the control condition for comparison with the S-cone stimulating chromatic light intervention.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of participants completing follow-up visits after each intervention periodTime frame: Throughout study participation (35 days)
  2. Percentage of daily flash surveys completed during the two 7-day stimulation periodsTime frame: Throughout the two 7-day stimulation periods (14 eligible survey timepoints during active treatment period)
  3. Percentage of prescribed light stimulation sessions completed based on participant self-reportTime frame: Throughout the two 7-day stimulation periods (14 eligible survey timepoints during active treatment period)

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • University of North Carolina at Chapel Hill

    Chapel Hill, North Carolina · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.